Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for the Treatment of Cervical Dystonia
2005-000709-70Phase 3Completed
- Sponsor
- Ipsen
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cervical dystonia (CD) comparing Dysport with Placebo (2 arms). Primary endpoint: Change from baseline in Toronto Western Spasmodic Torticollis Rating Scale. Started May 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2005-000709-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000709-70.